· Understand the druggable targets in the PSP pathogenetic process.

· Become familiar with active neuroprotection    trials for PSP.

· Learn about available symptomatic management of PSP.

Session date: 
06/06/2025 - 12:00pm to 1:00pm CDT
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation
Please login or create an account to proceed.
Speaker Name: 
Lawrence I. Golbe, MD